These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15365076)

  • 1. Telomerase expression predicts unfavorable outcome in osteosarcoma.
    Sanders RP; Drissi R; Billups CA; Daw NC; Valentine MB; Dome JS
    J Clin Oncol; 2004 Sep; 22(18):3790-7. PubMed ID: 15365076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
    Ulaner GA; Huang HY; Otero J; Zhao Z; Ben-Porat L; Satagopan JM; Gorlick R; Meyers P; Healey JH; Huvos AG; Hoffman AR; Ladanyi M
    Cancer Res; 2003 Apr; 63(8):1759-63. PubMed ID: 12702558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas.
    Scheel C; Schaefer KL; Jauch A; Keller M; Wai D; Brinkschmidt C; van Valen F; Boecker W; Dockhorn-Dworniczak B; Poremba C
    Oncogene; 2001 Jun; 20(29):3835-44. PubMed ID: 11439347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human telomerase reverse transcriptase splice variants is well correlated with low telomerase activity in osteosarcoma cell lines.
    Fujiwara-Akita H; Maesawa C; Honda T; Kobayashi S; Masuda T
    Int J Oncol; 2005 Apr; 26(4):1009-16. PubMed ID: 15753996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
    Dome JS; Bockhold CA; Li SM; Baker SD; Green DM; Perlman EJ; Hill DA; Breslow NE
    J Clin Oncol; 2005 Dec; 23(36):9138-45. PubMed ID: 16172460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR; Min K; Kim HS; Jung WW; Park YK
    Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience.
    Weiss A; Khoury JD; Hoffer FA; Wu J; Billups CA; Heck RK; Quintana J; Poe D; Rao BN; Daw NC
    Cancer; 2007 Apr; 109(8):1627-37. PubMed ID: 17351949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
    Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR
    Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of hRad21 and clinicopathological analysis in gastrointestinal malignant tumors maintained their telomeres by a mechanism of alternative lengthening of telomeres].
    Yi BQ; Zhao B; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):67-71. PubMed ID: 18197499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
    Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
    Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
    Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Hara Y; Waguri N; Suda T; Aoyagi Y; Hatakeyama K
    Transplant Proc; 2006 Dec; 38(10):3636-9. PubMed ID: 17175353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma.
    Laverdiere C; Hoang BH; Yang R; Sowers R; Qin J; Meyers PA; Huvos AG; Healey JH; Gorlick R
    Clin Cancer Res; 2005 Apr; 11(7):2561-7. PubMed ID: 15814634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma.
    Tabori U; Ma J; Carter M; Zielenska M; Rutka J; Bouffet E; Bartels U; Malkin D; Hawkins C
    J Clin Oncol; 2006 Apr; 24(10):1522-8. PubMed ID: 16575002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezrin expression predicts survival in stage IIB osteosarcomas.
    Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
    Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group.
    Schwartz CL; Gorlick R; Teot L; Krailo M; Chen Z; Goorin A; Grier HE; Bernstein ML; Meyers P;
    J Clin Oncol; 2007 May; 25(15):2057-62. PubMed ID: 17513810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome.
    Kersting C; Gebert C; Agelopoulos K; Schmidt H; van Diest PJ; Juergens H; Winkelmann W; Kevric M; Gosheger G; Brandt B; Bielack S; Buerger H
    Clin Cancer Res; 2007 May; 13(10):2998-3005. PubMed ID: 17505002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematogenous micrometastases in osteosarcoma patients.
    Bruland OS; Høifødt H; Saeter G; Smeland S; Fodstad O
    Clin Cancer Res; 2005 Jul; 11(13):4666-73. PubMed ID: 16000559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.